Skip to content
10-Q

Quarterly Report

UNITED THERAPEUTICS Corp UTHR

0001082554-25-000034

← back to feed
Filed
Oct 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 22, 2025 43.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 47.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.5M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $1B
Stock Repurchased Q3 2025 · Sep 30, 2024 $1B
Capex Q3 2025 · Sep 30, 2025 $347.6M
Capex Q3 2025 · Sep 30, 2024 $159.8M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $1.22B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $985.9M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.34B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.7B
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.59B
Stockholders Equity Q3 2025 · Jun 30, 2025 $7.17B
Stockholders Equity Q3 2025 · Dec 31, 2024 $6.44B
Stockholders Equity Q3 2025 · Sep 30, 2024 $6.1B
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.7B
Stockholders Equity Q3 2025 · Dec 31, 2023 $5.98B
Current Liabilities Q3 2025 · Sep 30, 2025 $546.3M
Current Liabilities Q3 2025 · Dec 31, 2024 $738.1M
Total Liabilities Q3 2025 · Sep 30, 2025 $760.9M
Total Liabilities Q3 2025 · Dec 31, 2024 $920M
Current Assets Q3 2025 · Sep 30, 2025 $3.49B
Current Assets Q3 2025 · Dec 31, 2024 $3.87B
Total Assets Q3 2025 · Sep 30, 2025 $7.35B
Total Assets Q3 2025 · Dec 31, 2024 $7.36B
Eps Diluted Q3 2025 · Sep 30, 2025 $7.16
Eps Diluted Q3 2025 · Sep 30, 2025 $20.17
Eps Diluted Q3 2025 · Sep 30, 2024 $6.39
Eps Diluted Q3 2025 · Sep 30, 2024 $18.43
Eps Basic Q3 2025 · Sep 30, 2025 $7.73
Eps Basic Q3 2025 · Sep 30, 2025 $21.76
Eps Basic Q3 2025 · Sep 30, 2024 $6.93
Eps Basic Q3 2025 · Sep 30, 2024 $19.73
Sga Expense Q3 2025 · Sep 30, 2025 $182.6M
Sga Expense Q3 2025 · Sep 30, 2025 $565.2M
Sga Expense Q3 2025 · Sep 30, 2024 $219.2M
Sga Expense Q3 2025 · Sep 30, 2024 $541.2M
Rd Expense Q3 2025 · Sep 30, 2025 $127.5M
Rd Expense Q3 2025 · Sep 30, 2025 $410.5M
Rd Expense Q3 2025 · Sep 30, 2024 $103.5M
Rd Expense Q3 2025 · Sep 30, 2024 $347.2M
Net Income Q3 2025 · Sep 30, 2025 $338.7M
Net Income Q3 2025 · Sep 30, 2025 $970.4M
Net Income Q3 2025 · Sep 30, 2024 $309.1M
Net Income Q3 2025 · Sep 30, 2024 $893.8M
Operating Income Q3 2025 · Sep 30, 2025 $388.5M
Operating Income Q3 2025 · Sep 30, 2025 $1.14B
Operating Income Q3 2025 · Sep 30, 2024 $343.1M
Operating Income Q3 2025 · Sep 30, 2024 $1.02B
Gross Profit Q3 2025 · Sep 30, 2025 $698.6M
Gross Profit Q3 2025 · Sep 30, 2025 $2.11B
Gross Profit Q3 2025 · Sep 30, 2024 $665.8M
Gross Profit Q3 2025 · Sep 30, 2024 $1.91B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $100.9M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $281M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $83.1M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $233.8M
Revenue Q3 2025 · Sep 30, 2025 $799.5M
Revenue Q3 2025 · Sep 30, 2025 $2.39B
Revenue Q3 2025 · Sep 30, 2024 $748.9M
Revenue Q3 2025 · Sep 30, 2024 $2.14B